Nuclear expression of Rac1 in cervical premalignant lesions and cervical cancer cells

BMC Cancer

Volumn 12, Issue , 2012, Pages

  Mendoza Catalán, Miguel A ^a   Cristóbal Mondragón, Gema R ^a   Adame Gómez, Jesús ^a   del Valle Flores, Heidi N ^a   Coppe, José F ^b   Sierra López, Laura ^b   Romero Hernández, Mirna A ^c   del Carmen Alarcón Romero, Luz ^c   Illades Aguiar, Berenice ^c   Castañeda Saucedo, Eduardo ^a  

^a UNIVERSIDAD AUTÓNOMA DE GUERRERO   (Mexico)

^b INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^c UACQB   (Mexico)

Author keywords

Carcinogenesis; Rac1; Rho GTPases; Risk factors

Indexed keywords

4 AMINO 6 [2 [[4 (DIETHYLAMINO) 1 METHYLBUTYL]AMINO] 6 METHYL 4 PYRIMIDINYL] 2 METHYLQUINOLINE; GUANINE NUCLEOTIDE EXCHANGE FACTOR; PROTEIN BETA PIX; PROTEIN CDC42; PROTEIN TIAM1; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN; RAC1 PROTEIN, HUMAN; TUMOR PROTEIN;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CELL NUCLEUS; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; ADULT; IMMUNOHISTOCHEMISTRY; METABOLISM; MIDDLE AGED; PRECANCER; RISK FACTOR; TUMOR CELL LINE; UTERINE CERVIX TUMOR; WESTERN BLOTTING;

ADULT; BLOTTING, WESTERN; CELL LINE, TUMOR; CELL NUCLEUS; FEMALE; GTP-BINDING PROTEINS; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; RAC1 GTP-BINDING PROTEIN; RISK FACTORS; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 84858720730     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-12-116     Document Type: Article

References (42)

1. Subramanya D, Grivas PD. HPV and cervical cancer: updates on an established relationship. Postgrad Med 2008, 120(4):7-13. 10.3810/pgm.2008.11.1928, 19020360.
2. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L. Chapter 1: HPV in the etiology of human cancer. Vaccine 2006, 24:(Suppl 3):S3/1-10.
3. Zur Hausen H. Papillomaviruses in the causation of human cancers - a brief historical account. Virology 2009, 384(2):260-5. 10.1016/j.virol.2008.11.046, 19135222.
4. Woodman CB, Collins SI, Young LS. The natural history of cervical HPV infection: unresolved issues. Nat Rev Cancer 2007, 7(1):11-22. 10.1038/nrc2050, 17186016.
5. Lagunas-Martinez A, Madrid-Marina V, Gariglio P. Modulation of apoptosis by early human papillomavirus proteins in cervical cancer. Biochim Biophys Acta 2010, 1805(1):6-16.
6. McLaughlin-Drubin ME, Munger K. The human papillomavirus E7 oncoprotein. Virology 2009, 384(2):335-344. 10.1016/j.virol.2008.10.006, 2661820, 19007963.
7. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63(6):1129-1136. 10.1016/0092-8674(90)90409-8, 2175676.
8. Boyer SN, Wazer DE, Band V. E7 protein of human papilloma virus-16 induces degradation of retinoblastoma protein through the ubiquitin-proteasome pathway. Cancer Res 1996, 56(20):4620-4624.
9. Jones DL, Alani RM, Munger K. The human papillomavirus E7 oncoprotein can uncouple cellular differentiation and proliferation in human keratinocytes by abrogating p21Cip1-mediated inhibition of cdk2. Genes Dev 1997, 11(16):2101-2111. 10.1101/gad.11.16.2101, 316455, 9284049.
10. Shin MK, Balsitis S, Brake T, Lambert PF. Human papillomavirus E7 oncoprotein overrides the tumor suppressor activity of p21Cip1 in cervical carcinogenesis. Cancer Res 2009, 69(14):5656-5663. 10.1158/0008-5472.CAN-08-3711, 2858290, 19584294.
11. Doorbar J. The papillomavirus life cycle. Clin Virol 2005, 32s:S7-S15.
12. Yan X, Shah W, Jing L, Chen H, Wang Y. High-risk human papillomavirus type 18 E7 caused p27 elevation and cytoplasmic localization. Cancer Biol Ther 2010, 9(9):728-35. 10.4161/cbt.9.9.11442, 20200484.
13. Villalonga P, Ridley AJ. Rho GTPases and cell cycle control. Growth Factors 2006, 24(3):159-164. 10.1080/08977190600560651, 17191359.
14. Heasman SJ, Ridley AJ. Mammalian Rho GTPases: new insights into their functions from in vivo studies. Nat Rev Mol Cell Biol 2008, 9(9):690-701. 10.1038/nrm2476, 18719708.
15. Bustelo XR, Sauzeau V, Berenjeno IM. GTP-binding proteins of the Rho/Rac family: regulation, effectors and functions in vivo. Bioessays 2007, 29(4):356-370. 10.1002/bies.20558, 1971132, 17373658.
16. Ellenbroek SI, Collard JG. Rho GTPases: functions and association with cancer. Clin Exp Metastasis 2007, 24(8):657-672. 10.1007/s10585-007-9119-1, 18000759.
17. Vega FM, Ridley AJ. Rho GTPases in cancer cell biology. FEBS Lett 2008, 582(14):2093-2101. 10.1016/j.febslet.2008.04.039, 18460342.
18. Karlsson R, Pedersen ED, Wang Z, Brakebusch C. Rho GTPase function in tumorigenesis. Biochim Biophys Acta 2009, 1796(2):91-98.
19. Srivastava S, Ramdass B, Nagarajan S, Rehman M, Mukherjee G, Krishna S. Notch1 regulates the functional contribution of RhoC to cervical carcinoma progression. Br J Cancer 2010, 102(1):196-205. 10.1038/sj.bjc.6605451, 2813755, 19953094.
20. He X, Qian Y, Cai H, Wang Z. The effect of RhoC siRNA on the invasiveness and proliferation of human cervical cancer cell line SiHa cells. J Huazhong Univ Sci Technolog Med Sci 2008, 28(6):665-669. 10.1007/s11596-008-0611-x, 19107362.
21. Nai MM, Yin RT, Xie C, Kang DY, Tang XL. The expression of RhoC and Ki67 in cervical intraepithelial neoplasia and squamous carcinoma of cervix. Sichuan Da Xue Xue Bao Yi Xue Ban 2009, 40(2):236-239.
22. Benitah SA, Valeron PF, van Aelst L, Marshall CJ, Lacal JC. Rho GTPases in human cancer: an unresolved link to upstream and downstream transcriptional regulation. Biochim Biophys Acta 2004, 1705(2):121-132.
23. Li XR, Ji F, Ouyang J, Wu W, Qian LY, Yang KY. Overexpression of RhoA is associated with poor prognosis in hepatocellular carcinoma. Eur J Surg Oncol 2006, 32(10):1130-1134. 10.1016/j.ejso.2006.05.012, 16806792.
24. Lanning CC, Ruiz-Velasco R, Williams CL. Novel mechanism of the co-regulation of nuclear transport of SmgGDS and Rac1. J Biol Chem 2003, 278(14):12495-12506. 10.1074/jbc.M211286200, 12551911.
25. Sandrock K, Bielek H, Schradi K, Schmidt G, Klugbauer N. The nuclear import of the small GTPase Rac1 is mediated by the direct interaction with karyopherin alpha2. Traffic 2010, 11(2):198-209. 10.1111/j.1600-0854.2009.01015.x, 19961560.
26. Michaelson D, Abidi W, Guardavaccaro D, Zhou M, Ahearn I, Pagano M, Philips MR. Rac1 accumulates in the nucleus during the G2 phase of the cell cycle and promotes cell division. J Cell Biol 2008, 181(3):485-496. 10.1083/jcb.200801047, 2364699, 18443222.
27. Buongiorno P, Pethe VV, Charames GS, Esufali S, Bapat B. Rac1 GTPase and the Rac1 exchange factor Tiam1 associate with Wnt-responsive promoters to enhance beta-catenin/TCF-dependent transcription in colorectal cancer cells. Mol Cancer 2008, 7:73. 10.1186/1476-4598-7-73, 2565678, 18826597.
28. Perez-Plasencia C, Duenas-Gonzalez A, Alatorre-Tavera B. Second hit in cervical carcinogenesis process: involvement of wnt/beta catenin pathway. Int Arch Med 2008, 1(1):10. 10.1186/1755-7682-1-10, 2491599, 18606007.
29. Bulut G, Fallen S, Beauchamp EM, Drebing LE, Sun J, Berry DL, Kallakury B, Crum CP, Toretsky JA, Schlegel R, et al. Beta-catenin accelerates human papilloma virus type-mediated cervical carcinogenesis in transgenic mice. PLoS One 2011, 6(11):e27243. 10.1371/journal.pone.0027243, 3210148, 22087269.
30. Yoshida T, Zhang Y, Rivera Rosado LA, Chen J, Khan T, Moon SY, Zhang B. Blockade of Rac1 activity induces G1 cell cycle arrest or apoptosis in breast cancer cells through downregulation of cyclin D1, survivin, and X-linked inhibitor of apoptosis protein. Mol Cancer Ther 2010, 9(6):1657-1668. 10.1158/1535-7163.MCT-09-0906, 20515940.
31. Yang C, Klein EA, Assoian RK, Kazanietz MG. Heregulin beta1 promotes breast cancer cell proliferation through Rac/ERK-dependent induction of cyclin D1 and p21Cip1. Biochem J 2008, 410(1):167-175. 10.1042/BJ20070781, 17941827.
32. Raptis L, Arulanandam R, Geletu M, Turkson J. The R(h)oads to Stat3: Stat3 activation by the Rho GTPases. Exp Cell Res 2011, 317(13):1787-1795. 10.1016/j.yexcr.2011.05.008, 3129747, 21619876.
33. Wu X, Tu X, Joeng KS, Hilton MJ, Williams DA, Long F. Rac1 activation controls nuclear localization of beta-catenin during canonical Wnt signaling. Cell 2008, 133(2):340-353. 10.1016/j.cell.2008.01.052, 2390926, 18423204.
34. Liu SC, Yang JJ, Shao KN, Chueh PJ. RNA interference targeting tNOX attenuates cell migration via a mechanism that involves membrane association of Rac. Biochem Biophys Res Commun 2008, 365(4):672-677. 10.1016/j.bbrc.2007.11.025, 18023414.
35. Amine A, Rivera S, Opolon P, Dekkal M, Biard DS, Bouamar H, Louache F, McKay MJ, Bourhis J, Deutsch E, et al. Novel anti-metastatic action of cidofovir mediated by inhibition of E6/E7, CXCR4 and Rho/ROCK signaling in HPV tumor cells. PLoS One 2009, 4(3):e5018. 10.1371/journal.pone.0005018, 2657827, 19325708.
36. Huang AC, Hsu SC, Kuo CL, Liao CL, Lai KC, Lin TP, Wu SH, Lu HF, Tang NY, Yang JS, et al. Involvement of Matrix Metalloproteinases in the Inhibition of Cell Invasion and Migration Through the Inhibition of NF-{kappa}B by the New Synthesized Ethyl 2-[N-p-chlorobenzyl-(2'-methyl)]anilino-4-oxo-4,5-dihydrofuran-3-carboxyla te (JOTO1007) in Human Cervical Cancer Ca Ski Cells. In Vivo 2009, 23(4):613-619.
37. Servitja JM, Marinissen MJ, Sodhi A, Bustelo XR, Gutkind JS. Rac1 function is required for Src-induced transformation. Evidence of a role for Tiam1 and Vav2 in Rac activation by Src. J Biol Chem 2003, 278(36):34339-34346. 10.1074/jbc.M302960200, 12810717.
38. Appledorn DM, Dao KH, O'Reilly S, Maher VM, McCormick JJ. Rac1 and Cdc42 are regulators of HRasV12-transformation and angiogenic factors in human fibroblasts. BMC Cancer 2010, 10:13. 10.1186/1471-2407-10-13, 2826294, 20067638.
39. Zhao X, Lu L, Pokhriyal N, Ma H, Duan L, Lin S, Jafari N, Band H, Band V. Overexpression of RhoA induces preneoplastic transformation of primary mammary epithelial cells. Cancer Res 2009, 69(2):483-491. 10.1158/0008-5472.CAN-08-2907, 2792911, 19147561.
40. Illades-Aguiar B, Alarcon-Romero Ldel C, Antonio-Vejar V, Zamudio-Lopez N, Sales-Linares N, Flores-Alfaro E, Fernandez-Tilapa G, Vences-Velazquez A, Munoz-Valle JF, Leyva-Vazquez MA. Prevalence and distribution of human papillomavirus types in cervical cancer, squamous intraepithelial lesions, and with no intraepithelial lesions in women from Southern Mexico. Gynecol Oncol 2010, 117(2):291-296. 10.1016/j.ygyno.2010.01.036, 20199804.
41. Fernandes JV, Meissner Rde V, Carvalho MG, Fernandes TA, Azevedo PR, de Azevedo JW, de Araujo JM. Human papillomavirus prevalence in women with normal cytology and with cervical cancer in Natal, Brazil. Mol Med Report 2011, 4(6):1321-1326.
42. Bayram A, Erkilic S, Balat O, Eksi F, Ugur MG, Ozturk E, Kaya G. Prevalence and genotype distribution of human papillomavirus in non-neoplastic cervical tissue lesion: cervical erosion. J Med Virol 2011, 83(11):1997-2003. 10.1002/jmv.22218, 21915876.